VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Summary

<< Previous

Bullboard Posts

Next >>

Comment by GrahamBon Feb 03, 2023 4:15am

89 Views

Post# 35264099

RE:Summary

ARIMA11 wrote: https://www.rally-co.ca/post/vpt-v-sales

Interesting.
A summary of the summary:

In short

“Ventripoint Diagnostics (VPT.V) traded between $0.22 and $0.63 cents in the period. Despite a strong revenue model and sizable addressable markets, VPT.V did not deliver revenues in FY2021 but managed to raise $8M in funds.”

“Based on the financial performance in FY2021 and YTD 2022, its evident that the VMS +3.0 is facing barriers to adoptions. It may be that the demand is simply not there because the awareness of its capacities are lagging”

Source: https://www.rally-co.ca/post/vpt-v-monetization

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario